Showing 291-300 of 9095 results for "".
PR Is the Next Big Thing for Online Dermatology Marketing
https://practicaldermatology.com/topics/practice-management/pr-is-the-next-big-thing-for-online-dermatology-marketing/22954/Dermatology marketers should evaluate current SEO to make room for public relations strategies.Neal Bhatia, MD
https://practicaldermatology.com/topics/practice-management/neal-bhatia-md/22950/Dr. Neal Bhatia is an Associate Professor of Dermatology at Harbor UCLA and is also in private practice in Long Beach, CA. He has published articles on a wide range of topics covering both medical and cosmetic dermatology, and he completed a oneyear appointment on the AAD Board of Directors. Ahead,Medical Meets Cosmetic in Dermatology
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/medical-meets-cosmetic-in-dermatology/21550/The contrast between cosmetic and medical may appear sharp, but a sound approach to dermatology requires both balance and blend.Business Advisor: Telephone Receptionists Can Make or Break a Practice
https://practicaldermatology.com/topics/general-topics/telephone-receptionists-can-make-or-break-a-practice/21997/Learn to successfully manage phone calls and boost patients' experiences before they set foot in your practice.Meet the Moys: Father and Daughter Dermatologists Reflect on the Specialty
https://practicaldermatology.com/topics/feature/moy-father-daughter-reflect-on-dermatology-specialty/26578/Meet the Moys: Father and Daughter Dermatologists Reflect on the SpecialtyTNF Inhibitors and the Risk of Melanoma
https://practicaldermatology.com/topics/skin-cancer-photoprotection/tnf-inhibitors-and-the-risk-of-melanoma/21519/New research offers a deeper look into the potential elevated risk for malignant melanoma from TNF treatment.Test Your Skills and Learn From Experts on IL-13 Inhibitors in Moderate to Severe Atopic Dermatitis
https://practicaldermatology.com/programs/cme/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/Watch an expert-led case discussion on the role of IL-13 in moderate to severe atopic dermatitis and the efficacy on its inhibition through biologic therapies to achieve control.Professionalism in the Workplace: Tips for Managers
https://practicaldermatology.com/topics/practice-management/professionalism-in-the-workplace-tips-for-managers/20514/Maintaining the highest possible level of professionalism can help new and seasoned managers navigate challenges and position themselves to take advantage of additional opportunities.Successful Meetings: It's All About the Follow-up
https://practicaldermatology.com/topics/practice-management/successful-meetings-its-all-about-the-follow-up/20456/Frustrated by meetings that are run well but produce limited results? Then try keeping an eye on what happens afterwards.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://practicaldermatology.com/series/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.